Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

mehr ...

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 741, Suchdauer: 1.12s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial

von Couffin-Cadièrgues, Sandrine ; Espérou, Hélène ; Investigators ; et al.

In Clinical Microbiology and Infection April 2026 32(4):618-628
- View full text via DOI
Merkliste

2
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques

von Letscher, Hélène ; Guilligay, Delphine ; Effantin, Gregory ; et al.

npj Vaccines. 10(1)
- Zum Volltext in PubMed Central
Merkliste

3
Neutralizing human monoclonal antibodies that target the PcrV component of the type III secretion system of Pseudomonas aeruginosa act through distinct mechanisms

von Jean-Mathieu Desveaux ; Eric Faudry ; Carlos Contreras-Martel ; et al.

eLife, Vol 14 (2026)

Schlagworte: Pseudomonas aeruginosa; B cell; Antibody; virulence factors; T3SS; Medicine; Science; Biology (General); QH301-705.5
- View full text via DOI
Merkliste

4
Neutralizing human monoclonal antibodies that target the PcrV component of the type III secretion system of Pseudomonas aeruginosa act through distinct mechanisms

von Desveaux, Jean-Mathieu ; Faudry, Eric ; Contreras-Martel, Carlos ; et al.

EISSN: 2050-084X ; eLife ; https://hal.science/hal-05518877 ; eLife, 2026, 14, pp.RP105195. ⟨10.7554/eLife.105195.3⟩

Schlagworte: [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases; [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry; Molecular Biology/Structural Biology [q-bio.BM]; [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy; [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
- View full text via BASE
Merkliste

5
Pre-existing anti-vector immunity to adenovirus-inspired VLP vaccines shows an adjuvant-dependent antagonism

von Gallet, Salomé ; Hannani, Dalil ; Dergan-Dylon, Sebastian ; et al.

EISSN: 2076-393X ; Vaccines ; https://hal.science/hal-04970602 ; Vaccines, 2025, 13 (3), pp.238. ⟨10.3390/vaccines13030238⟩ ; https://www.mdpi.com/2076-393X/13/3/238

Schlagworte: [SDV]Life Sciences [q-bio]
- View full text via BASE
Merkliste

6
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.

von Amen, Axelle ; Yoo, Randy ; Fabra-García, Amanda ; et al.
- View full text via BASE
Merkliste

7
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants

von Léa Dépéry ; Isabelle Bally ; Axelle Amen ; et al.

Microbiology Spectrum, Vol 13, Iss 1 (2025)

Schlagworte: SARS-CoV-2; serology; neutralizing antibodies; Omicron; COVID; Microbiology; QR1-502
- View full text via DOI
Merkliste

8
Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform

von Chevillard, Christopher ; Amen, Axelle ; Besson, Solène ; et al.

In Molecular Therapy 4 May 2022 30(5):1913-1925
- View full text via DOI
Merkliste

9
Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein

von Isabelle Bally ; Guillaume Drumont ; Véronique Rossi ; et al.

Frontiers in Immunology, Vol 15 (2024)

Schlagworte: complement system; lectin pathway; MASP-2; SARS-CoV-2; nucleoprotein; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

10
SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy

von Aurélie Truffot ; Julien Andréani ; Marion Le Maréchal ; et al.

Emerging Infectious Diseases, Vol 27, Iss 10, Pp 2725-2728 (2021)

Schlagworte: coronavirus disease; COVID-19; severe acute respiratory syndrome coronavirus 2; SARS-CoV-2; coronaviruses; viruses; Medicine; Infectious and parasitic diseases; RC109-216
- View full text via DOI
Merkliste

11
Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies.

von Collin Joyce ; Sasha Murrell ; Ben Murrell ; et al.

PLoS Pathogens, Vol 19, Iss 6, p e1011416 (2023)

Schlagworte: Immunologic diseases. Allergy; RC581-607; Biology (General); QH301-705.5
- View full text via DOI
Merkliste

12
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

von Antonin Bal ; Karen Brengel-Pesce ; Alexandre Gaymard ; et al.

Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)

Schlagworte: Medicine; Science
- View full text via DOI
Merkliste

13
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

von Hites, Maya ; Massonnaud, Clément ; Lapique, Eva Larranaga ; et al.

ISSN: 0163-4453.

Schlagworte: MESH: Humans; MESH: Antibodies; Monoclonal; Neutralizing; MESH: COVID-19; MESH: Drug Combinations; MESH: Randomized Controlled Trials as Topic; MESH: Clinical Trials; Phase III as Topic; [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
- View full text via BASE
Merkliste

14
Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study

von Bal, Antonin ; Brengel-Pesce, Karen ; Gaymard, Alexandre ; et al.

Scientific Reports. 11(1)
- Zum Volltext in PubMed Central
Merkliste

15
Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome

von Giovanna Clavarino ; Corentin Leroy ; Olivier Epaulard ; et al.

Frontiers in Immunology, Vol 13 (2022)

Schlagworte: SARS-CoV-2; COVID-19; lymphocytes; flow cytometry; disease severity; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

16
Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality

von Federica Defendi ; Corentin Leroy ; Olivier Epaulard ; et al.

Frontiers in Immunology, Vol 12 (2021)

Schlagworte: COVID-19; complement; alternative pathway; MBL; lectin pathway; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

17
An MPER antibody neutralizes HIV-1 using germline features shared among donors

von Lei Zhang ; Adriana Irimia ; Lingling He ; et al.

Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)

Schlagworte: Science
- View full text via DOI
Merkliste

18
Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design

von Rantalainen, Kimmo ; Berndsen, Zachary T. ; Murrell, Sasha ; et al.

In Cell Reports 12 June 2018 23(11):3249-3261
- View full text via DOI
Merkliste

19
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats

von Amen, Axelle ; Yoo, Randy ; Fabra-García, Amanda ; et al.

EISSN: 2050-084X ; eLife ; https://hal.science/hal-04717738 ; eLife, 2024, 13, pp.1-28. ⟨10.7554/eLife.97865.2⟩

Schlagworte: [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology; [SDV.IMM.VAC]Life Sciences [q-bio]/Immunology/Vaccinology; [SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
- View full text via BASE
Merkliste

20
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans

von Sok, Devin ; Pauthner, Matthias ; Briney, Bryan ; et al.

In Immunity 19 July 2016 45(1):31-45
- View full text via DOI
Merkliste

21
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

22
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design

von Andrabi, Raiees ; Voss, James E. ; Liang, Chi-Hui ; et al.

In Immunity 17 November 2015 43(5):959-973
- View full text via DOI
Merkliste

23
Profiling human antibody responses by integrated single-cell analysis

von Ogunniyi, Adebola O. ; Thomas, Brittany A. ; Politano, Timothy J. ; et al.

In Vaccine 19 May 2014 32(24):2866-2873
- View full text via DOI
Merkliste

24
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.

von UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology ; UCL - (SLuc) Service de médecine interne et maladies infectieuses (MIMI) ; Hites, Maya ; et al.

The Journal of infection, Vol. 88, no.3, p. 106120 (2024)

Schlagworte: info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

25
Author response: Neutralizing human monoclonal antibodies that target the PcrV component of the type III secretion system of Pseudomonas aeruginosa act through distinct mechanisms

von Desveaux, Jean-Mathieu ; Faudry, Eric ; Contreras-Martel, Carlos ; et al.
- View full text via BASE
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag